Imaging helps predict head and neck cancer survival

04/4/2013 | AuntMinnie.com (free registration)

A study published in the Journal of Nuclear Medicine found that in patients with head and neck cancer undergoing initial radiotherapy or chemoradiotherapy, a drop of at least 45% in the maximum standardized uptake value on FLT-PET/CT scans and a decrease of at least 31% in gross tumor volume measured using visual delineation were linked with a three-year disease-free survival rate of 88%. Three-year disease-free survival was 63% for other patients. Scans undertaken in the second week of therapy were the most useful in customizing treatment, researchers said.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC